ABBV Analyst Ratings
AbbVie Inc. (ABBV) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $500.93B, listed on NYSE, employing roughly 57,000 people, carrying a beta of 0.28 to the broader market. AbbVie Inc. Led by Robert A. Michael, public since 2013-01-02.
Analyst Ratings
In the October 2026 monthly count, 30 analysts rated ABBV: 8 Strong Buy, 16 Buy, 5 Hold, 0 Sell and 1 Strong Sell.
Twelve months earlier, in October 2025: 29 analysts, 5 Strong Buy, 14 Buy, 9 Hold, 0 Sell and 1 Strong Sell.
Price Targets
- Average Target
- $292.21
- Median Target
- $300.00
- High
- $320.00
- Low
- $235.00
- Targets Published, Last 12 Months
- 43
Recent Price Targets
The 5 most recent of 43 price targets published in the last 12 months.
| Date | Firm | Analyst | Target | Price When Posted |
|---|---|---|---|---|
| Oct 8, 2026 | Cantor Fitzgerald | Carter Gould | $290.00 | $271.36 |
| Oct 7, 2026 | Morgan Stanley | Not named | $310.00 | $271.89 |
| Oct 6, 2026 | Scotiabank | Louise Chen | $320.00 | $265.21 |
| Sep 10, 2026 | HSBC | Rajesh Kumar | $315.00 | $250.98 |
| Aug 20, 2026 | Piper Sandler | Not named | $303.00 | $265.97 |
Recent Upgrades & Downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Oct 9, 2026 | UBS | maintain | Neutral | Neutral |
| Oct 9, 2026 | Guggenheim | maintain | Buy | Buy |
| Oct 8, 2026 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Oct 8, 2026 | JP Morgan | maintain | Overweight | Overweight |
Quantitative Rating
ABBV carries a model grade of C (overall score 2 of 5), computed from six valuation and financial measures (discounted cash flow, return on equity, return on assets, debt to equity, price to earnings and price to book), each scored 1 to 5. It is not an analyst rating.
How to Read ABBV Analyst Coverage
Sell-side equity analysts publish three primary outputs: ratings (Strong Buy / Buy / Hold / Sell / Strong Sell, or firm-specific equivalents), price targets, and EPS / revenue estimate revisions. Rating consensus moves slowly relative to price; it reflects 12-month directional conviction rather than near-term momentum. Price targets are more responsive but typically drift behind realized price during sharp moves. The most actionable signal for options traders is a cluster of ratings actions across multiple firms within a short window, which compresses or expands implied volatility on a horizon of days to weeks and shifts the put-call skew toward the directional consensus. The recent-actions table above shows the five most recent firm-level changes; longer histories live behind aggregator sources.
For event-driven options sizing, pair the consensus rating and target distribution with the implied-volatility surface and dealer-positioning view. Aggressive target hikes from multiple firms tend to tighten put skew (downside protection becomes relatively cheaper); aggressive cuts widen put skew. The size of the IV response in the hours after a rating change is visible on the per-ticker volatility skew page and the gamma-exposure page, both of which show how dealer hedging propagates the analyst-driven flow into the listed options chain.
Learn how analyst ratings is reported and how to read the data →
Frequently asked ABBV analyst ratings questions
- What is the ABBV consensus price target?
- As of the latest aggregator update, AbbVie Inc. (ABBV) carries a consensus 12-month price target of $292.21. Target ranges run from a low of $235.00 to a high of $320.00. The target is the average of the price targets published by sell-side equity analysts covering the name.
- What is the analyst rating consensus on ABBV?
- In the October 2026 monthly count, 30 analysts rated ABBV, and the distribution tilts to the Buy side: 8 Strong Buy, 16 Buy, 5 Hold, 0 Sell and 1 Strong Sell. Rating consensus moves slowly relative to price; it reflects sell-side conviction over a 12-month horizon rather than near-term momentum.
- What recent ratings actions has ABBV seen?
- The five most recent ratings actions on ABBV appear on the page above. Sell-side rating changes are watched for two reasons: an upgrade or downgrade with a meaningful target revision moves the consensus and can trigger short-term positioning shifts, and the firm-level rating cluster (multiple firms moving in the same direction within a short window) is a clearer signal than any single action. Options markets often price the implied-vol response within minutes of the announcement.
- How do analyst targets affect ABBV options pricing?
- Analyst target revisions tend to be priced in by the lit options market within minutes of publication, but persistent target drift over weeks does correlate with implied-volatility movement. Aggressive target hikes from multiple firms inside a single quarter tighten put skew (downside protection becomes cheaper relative to upside speculation); aggressive cuts widen put skew. The most actionable read is the implied-vol response in the hours after a target change, which is visible on the per-ticker volatility skew page.